Patent details
92233 Product Name: "Sativex et ses dérivés pharmaceutiquement acceptables"
Basic Information
- Publication number:
- 92233
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP037879004
- Legal Status:
- Expired
- Application number:
- 92233
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
1
- Marketing Authorization Number:
- LU 20120221
- Marketing Authorization Type:
- Marketing Authorization Date:
- 01/01/2013
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
2
- Marketing Authorization Number:
- GB PL 18024/0009
- Marketing Authorization Type:
- Marketing Authorization Date:
- 16/06/2010
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 26/06/2013
- First Marketing Authorization date:
- 16/06/2010
- Grant date:
- 26/08/2013
- Activation date:
- 14/08/2023
- Publication date:
- 26/08/2013
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 16/06/2025
- SPC Extension Expiration:
- 16/06/2025
- Rejection date:
- Withdrawal date:
Owner
- From:
- 26/06/2013
- Name:
- GW Pharma Limited
- Address:
- Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, United Kingdom (GB)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/06/2013
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- WHITTLE Brian, Anthony
- Address:
- United Kingdom (GB)
Publication
Bulletin
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 09/07/2024
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- OFFICE FREYLINGER S.A.
| Filing date | Document type | Number of pages |
|---|